Is Heartflow, Inc. Common Stock (HTFL) a Buy, Sell, or Hold?
NASDAQ : HTFL
Heartflow, Inc. Common Stock — Insider Trades
$24.12 USD
-$0.49 (-1.99%)
- Volume
- 863.19K
- Average Volume
- 1.48M
- Market Capitalization
- $2.08B
- P/E Ratio
- -27.39
- Dividend Yield
- 0.00%
- Price Target
- $37.00
- Year High
- $41.22
- Year Low
- $20.13
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.57
Insider Activity Summary (Last 12 Months)
Insiders Buying
36
Insiders Selling
54
Amount of Insider Selling
$9.32M
HTFL Insider Buying/Selling by Quarter
HTFL Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Verghese Vikram | officer: Chief Financial Officer | 2026-07-21 | M-Exempt | 2.22 | 2026-07-23 |
| Verghese Vikram | officer: Chief Financial Officer | 2026-07-21 | M-Exempt | 2.22 | 2026-07-23 |
| BARABE TIMOTHY C | director | 2026-07-17 | M-Exempt | 19 | 2026-07-20 |
| BARABE TIMOTHY C | director | 2026-07-17 | M-Exempt | 19 | 2026-07-20 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-07-15 | M-Exempt | 19 | 2026-07-17 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-07-15 | M-Exempt | 19 | 2026-07-17 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-07-15 | S-Sale | 25.72 | 2026-07-17 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-07-10 | S-Sale | 27.75 | 2026-07-13 |
| WELDON WILLIAM C | director | 2026-07-08 | M-Exempt | 8.33 | 2026-07-10 |
| WELDON WILLIAM C | director | 2026-07-08 | M-Exempt | 8.33 | 2026-07-10 |
| WELDON WILLIAM C | director | 2026-07-08 | M-Exempt | 8.33 | 2026-07-10 |
| WELDON WILLIAM C | director | 2026-07-08 | M-Exempt | 8.33 | 2026-07-10 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-06-24 | S-Sale | 35 | 2026-06-26 |
| WELDON WILLIAM C | director | 2026-06-16 | A-Award | 32.05 | 2026-06-18 |
| BARABE TIMOTHY C | director | 2026-06-16 | A-Award | 32.05 | 2026-06-18 |
| Cullivan Julie A | director | 2026-06-16 | A-Award | 32.05 | 2026-06-18 |
| Lightcap Jeffrey C | director | 2026-06-16 | A-Award | 32.05 | 2026-06-18 |
| Riley Wayne Joseph | director | 2026-06-16 | A-Award | 32.05 | 2026-06-18 |
| Tansey Casey M | director | 2026-06-16 | A-Award | 32.05 | 2026-06-18 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-06-15 | M-Exempt | 2.22 | 2026-06-17 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-06-15 | M-Exempt | 2.22 | 2026-06-17 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-06-10 | S-Sale | 28.5 | 2026-06-12 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-05-18 | M-Exempt | 19 | 2026-05-20 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-05-18 | M-Exempt | 19 | 2026-05-20 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-05-18 | S-Sale | 28.34 | 2026-05-20 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-05-11 | S-Sale | 29.12 | 2026-05-13 |
| Jones Marie L. | officer: Chief Accounting Officer | 2026-05-06 | F-InKind | 30.29 | 2026-05-08 |
| Jones Marie L. | officer: Chief Accounting Officer | 2026-05-07 | F-InKind | 29.98 | 2026-05-08 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-05-06 | F-InKind | 30.29 | 2026-05-08 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-05-07 | F-InKind | 29.98 | 2026-05-08 |
| Verghese Vikram | officer: Chief Financial Officer | 2026-05-06 | F-InKind | 30.29 | 2026-05-08 |
| Verghese Vikram | officer: Chief Financial Officer | 2026-05-07 | F-InKind | 29.98 | 2026-05-08 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-05-06 | F-InKind | 30.29 | 2026-05-08 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-05-07 | F-InKind | 29.98 | 2026-05-08 |
| Bain Capital Life Sciences Investors, LLC | 10 percent owner | 2026-04-28 | S-Sale | 30.51 | 2026-04-30 |
| Bain Capital Life Sciences Investors, LLC | 10 percent owner | 2026-04-29 | S-Sale | 29.37 | 2026-04-30 |
| Bain Capital Life Sciences Investors, LLC | 10 percent owner | 2026-04-30 | S-Sale | 29.18 | 2026-04-30 |
| Bain Capital Life Sciences Investors, LLC | 10 percent owner | 2026-04-30 | S-Sale | 30.05 | 2026-04-30 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-04-10 | S-Sale | 26.72 | 2026-04-14 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 2.22 | 2026-04-03 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 2.22 | 2026-04-03 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 2.22 | 2026-04-03 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 2.22 | 2026-04-03 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 2.22 | 2026-04-03 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-04-01 | S-Sale | 24.64 | 2026-04-03 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 8.33 | 2026-04-03 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 8.33 | 2026-04-03 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 2.22 | 2026-04-03 |
| Lightcap Jeffrey C | director | 2026-03-24 | J-Other | 0 | 2026-03-26 |
| HealthCor Partners Management LP | director | 2026-03-24 | J-Other | 0 | 2026-03-26 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-03-19 | M-Exempt | 2.22 | 2026-03-23 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-03-19 | M-Exempt | 2.22 | 2026-03-23 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-03-19 | M-Exempt | 2.22 | 2026-03-23 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-03-19 | M-Exempt | 2.22 | 2026-03-23 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-03-19 | S-Sale | 25.6928 | 2026-03-23 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-03-18 | S-Sale | 25 | 2026-03-20 |
| BARABE TIMOTHY C | director | 2026-03-11 | M-Exempt | 2.22 | 2026-03-12 |
| BARABE TIMOTHY C | director | 2026-03-11 | M-Exempt | 2.22 | 2026-03-12 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-03-06 | A-Award | 16.15 | 2026-03-12 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-03-10 | S-Sale | 22.66 | 2026-03-12 |
| Cullivan Julie A | director | 2026-03-05 | S-Sale | 25 | 2026-03-06 |
| BARABE TIMOTHY C | director | 2026-02-17 | M-Exempt | 8.33 | 2026-02-19 |
| BARABE TIMOTHY C | director | 2026-02-17 | M-Exempt | 8.33 | 2026-02-19 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-02-12 | M-Exempt | 2.22 | 2026-02-17 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-02-12 | M-Exempt | 2.22 | 2026-02-17 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-02-12 | M-Exempt | 2.22 | 2026-02-17 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-02-12 | M-Exempt | 8.33 | 2026-02-17 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-02-12 | M-Exempt | 2.22 | 2026-02-17 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-02-12 | S-Sale | 24.4883 | 2026-02-17 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-02-12 | M-Exempt | 8.33 | 2026-02-17 |
| Jones Marie L. | officer: Chief Accounting Officer, VP | 2026-02-06 | A-Award | 27.74 | 2026-02-10 |
| Jones Marie L. | officer: Chief Accounting Officer, VP | 2026-02-06 | A-Award | 0 | 2026-02-10 |
| Jones Marie L. | officer: Chief Accounting Officer, VP | 2026-02-06 | F-InKind | 27.74 | 2026-02-10 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-02-06 | A-Award | 0 | 2026-02-10 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-02-10 | S-Sale | 27.46 | 2026-02-10 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-02-06 | F-InKind | 27.74 | 2026-02-10 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2026-02-06 | A-Award | 27.74 | 2026-02-10 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-02-06 | A-Award | 27.74 | 2026-02-10 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-02-06 | A-Award | 0 | 2026-02-10 |
| Rogers Campbell | officer: Chief Medical Officer | 2026-02-06 | F-InKind | 27.74 | 2026-02-10 |
| Verghese Vikram | officer: Chief Financial Officer | 2026-02-06 | A-Award | 0 | 2026-02-10 |
| Verghese Vikram | officer: Chief Financial Officer | 2026-02-06 | F-InKind | 27.74 | 2026-02-10 |
| Verghese Vikram | officer: Chief Financial Officer | 2026-02-06 | A-Award | 27.74 | 2026-02-10 |
| Cullivan Julie A | director | 2026-02-05 | S-Sale | 27.32 | 2026-02-06 |
| Bain Capital Life Sciences Investors, LLC | 10 percent owner | 2026-02-04 | S-Sale | 28.05 | 2026-02-06 |
| Lightcap Jeffrey C | director | 2025-12-16 | P-Purchase | 26.342 | 2025-12-17 |
| Rogers Campbell | officer: Chief Medical Officer | 2025-11-07 | F-InKind | 32.56 | 2025-11-12 |
| Farquhar John C.M. | director, officer: Chief Executive Officer | 2025-11-07 | F-InKind | 32.56 | 2025-11-12 |
| Verghese Vikram | officer: Chief Financial Officer | 2025-11-07 | F-InKind | 32.56 | 2025-11-12 |
| Jones Marie L. | officer: Chief Accounting Officer, VP | 2025-11-07 | F-InKind | 32.56 | 2025-11-12 |